Neuromuscular Dysfunction
VIDEO: New therapies bring progress, uncertainties in Friedreich’s ataxia management
In this video David Lynch, MD, PhD, discusses therapies in the pipeline for Friedreich's ataxia.
Q&A: ‘Dawn of a new era for OSA care’ moving into 2025
Entering 2025, adults with moderate to severe obstructive sleep apnea and obesity have a new FDA-approved treatment option that takes the form of a GIP/GLP-1 dual agonist, according to a press release from Eli Lilly and Company.
Neuromuscular exercise, pain neuroscience education may improve chronic pain after TKA
Neuromuscular exercise and pain neuroscience education did not yield superior outcomes to education alone, however, interventions may improve clinical, pain and functional outcomes after total knee arthroplasty, according to published data.
FDA clears electrical muscle stimulator suit for neuromuscular injuries, disease
The FDA has granted 510(k) clearance to Neuro20 Technologies for its Neuro20 Pro System, a wearable whole-body electrical muscle stimulator suit, software and operating system for neuromuscular injuries and disease.